XPAR
LNA
Market cap264mUSD
Oct 09, Last price
23.80EUR
1D
1.71%
1Q
-31.41%
Jan 2017
-32.67%
IPO
126.24%
Name
LNA Sante SA
Chart & performance
P/E
10.15
P/S
0.27
EPS
2.35
Div yield, %
2.84%
Shrs. gr., 5y
1.37%
Rev. gr., 5y
9.72%
Revenues
913m
+13.15%
Net income
24m
+10.68%
CFO
70m
-36.23%
Dividend
Sep 28, 20260.95 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1990 and headquartered in Vertou, France, LNA Santé SA specializes in the administration and operation of a diverse portfolio of healthcare facilities. These include residences for the elderly, medical and rehabilitative care centers, home-based hospitalization services, mental health clinics, and general health hubs.
Related entities
Subsidiaries (7)
IMMOBILIERE DE LA FONTENELLE
LE CLOS CHAMPIROL
LNA BELGIQUE
LNA INTERNATIONAL
LNA RETRAITE
LES JARDINS D' OLONNE
RESIDENCE DES SOURCES
Key people
Jean-Paul Siret
Non-Executive Chairman of the Board · since 2021
Damien Billard
Deputy Chief Executive Officer, Chief Financial Officer, Executive Director · since 2009
Willy Siret
Chief Executive Officer, Executive Director · since 2021
Guillaume Berthelot
Non-Executive Director · since 2024
Laura Boisquillon
Non-Executive Director - Representative of Employees · since 2020
Franck Lebon
Non-Executive Director - Permanent Representative of LNA Ensemble · since 2021
Rita Michel
Non-Executive Director - Representative of Employees · since 2024
Christine Passerat
Non-Executive Director · since 2021
Anne-Marie Armanteras
Non-Executive Independent Director · since 2023
Emmanuelle Duez
Non-Executive Independent Director · since 2023
Christine Lioret
Non-Executive Independent Director · since 2017
Flavie Lorre
Non-Executive Independent Director · since 2017
Veronique Rival
Non-Executive Independent Director · since 2021
Damien Verdier
Non-Executive Independent Director · since 2021
Headquarters & legal address
7 BOULEVARD AUGUSTE PRIOU
VERTOU 44120
FR
VERTOU 44120
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||